Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) EBT (2019 - 2023)

Historic EBT for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to -$45.4 million.

  • ADC Therapeutics' EBT rose 1152.98% to -$45.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$157.8 million, marking a year-over-year decrease of 1730.71%. This contributed to the annual value of -$154661.0 for FY2022, which is 3850.58% up from last year.
  • ADC Therapeutics' EBT amounted to -$45.4 million in Q3 2023, which was up 1152.98% from -$52.7 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year EBT high stood at -$20190.0 for Q4 2022, and its period low was -$126.5 million during Q2 2020.
  • Moreover, its 5-year median value for EBT was -$45.4 million (2023), whereas its average is -$39.9 million.
  • Per our database at Business Quant, ADC Therapeutics' EBT plummeted by 54369031.56% in 2020 and then surged by 6532.28% in 2022.
  • Quarter analysis of 5 years shows ADC Therapeutics' EBT stood at -$35170.0 in 2019, then crashed by 57707.79% to -$20.3 million in 2020, then soared by 99.72% to -$56352.0 in 2021, then surged by 64.17% to -$20190.0 in 2022, then plummeted by 224773.7% to -$45.4 million in 2023.
  • Its EBT was -$45.4 million in Q3 2023, compared to -$52.7 million in Q2 2023 and -$59.7 million in Q1 2023.